Tru Niagen Review: What the Evidence Says About ChromaDex's NR Supplement

Written by the Nuvirox Research Team

Short answer: Tru Niagen has the strongest research pedigree of any consumer NR supplement — with a real honest caveat about what "research-backed" actually means here. ChromaDex's Tru Niagen is frequently recommended by longevity researchers and often appears at the top of independent supplement reviews. This standing is earned — the Niagen® NR ingredient has been used in more peer-reviewed human trials than any other commercial NR product, ChromaDex holds extensive IP protecting it, and the company received FDA GRAS (Generally Recognized as Safe) status in 2016. The honest caveat is that being the most-studied doesn't automatically mean the clinical outcomes are proven. This review distinguishes between what the evidence actually shows and what the marketing implies.

What is Tru Niagen, exactly?

Tru Niagen is ChromaDex's direct-to-consumer NR supplement. Each vegetarian capsule contains 300 mg of Niagen® (nicotinamide riboside chloride) with no other active ingredients — just microcrystalline cellulose and hypromellose (the capsule shell). The serving is one capsule per day (300 mg), though some people take two (600 mg). It's sold directly at truniagen.com and through major retailers including Amazon, Costco, and some pharmacies, typically at $40–50/month for 30 servings.

The Niagen® ingredient is what distinguishes Tru Niagen from generic NR supplements. ChromaDex holds or exclusively licenses over 40 patents covering NR's composition, manufacturing, and uses as an NAD+ precursor — patents originating from foundational academic research at Cornell, Dartmouth, and Queen's University Belfast. ChromaDex is the sole commercial supplier of this specific NR form to research institutions, meaning virtually every published human RCT using NR has used Niagen®. That's not true of generic NR from Chinese manufacturers sold under other brands.

What human studies show about Niagen® NR

The Martens et al. (2018) crossover — the pharmacokinetics foundation. Twenty-four healthy adults aged 55–79 were randomized to 6 weeks of NR (500 mg twice daily = 1,000 mg/day) or placebo in a double-blind crossover design. NR supplementation raised whole blood NAD+ by approximately 60% above baseline. The study also suggested improvements in blood pressure and arterial stiffness in the subgroup with elevated baseline blood pressure. No serious adverse events. Published in Nature Communications. (DOI: 10.1038/s41467-018-03421-7)

The Dellinger et al. (2017) Elysium Basis RCT — NR + pterostilbene. 120 healthy adults aged 60–80 were randomized to standard dose (250 mg NR + 50 mg pterostilbene), double dose, or placebo for 8 weeks. NAD+ increased 40% at standard dose and 90% at double dose vs. baseline; no significant change in placebo. This trial used a formulation combining NR and pterostilbene — not pure Niagen® alone — but the NR component is Niagen®. Published in npj Aging and Mechanisms of Disease. (DOI: 10.1038/s41514-017-0016-9)

The honest counterweight: NAD+ elevation ≠ proven clinical benefit. Neither of these trials — nor any of the 20+ NR human trials published to date — has used clinical outcomes like cardiovascular event rates, cognitive function over years, or verified mortality as primary endpoints. Trials showing NAD+ elevation have demonstrated a reliable pharmacokinetic effect. Whether that effect translates to meaningful health improvement in healthy adults remains genuinely uncertain. A 2024 review in Nature Aging (Henriquez-Olguin et al.) noted that evidence for age-related NAD+ decline in humans is more limited than often claimed, and clinical trial outcomes have been inconsistent. (DOI: 10.1038/s41514-023-00134-0)

What users actually report, and what the safety data says

Across published NR trials, NR has been consistently well-tolerated. The most commonly reported effects are mild and transient: occasional nausea, headache, or mild flushing (notably, NR does not cause the intense flushing associated with nicotinic acid/niacin — this is a meaningful pharmacological difference). Several independent users report noticing improved sleep quality and reduced fatigue, though these outcomes haven't been reliably demonstrated in controlled trials. Some users report no subjective effects at all after weeks of use — which is consistent with the trial data (the main measurable effect is in a blood test, not necessarily in symptoms). ChromaDex notes that results may take 4–8 weeks of consistent use before subjective effects, if any, are noticeable.

How does Tru Niagen compare to NMN supplements?

This is one of the most common questions in this space — and our full NR vs. NMN comparison goes deep on it. The short version for Tru Niagen specifically: NR (Niagen®) has more published human RCT data supporting its safety and NAD+ elevation effect than any NMN product currently available. NMN has shown equivalent or sometimes greater NAD+ elevation in some human trials, and may reach NAD+ via a slightly different cellular entry pathway. No large, well-controlled head-to-head trial has directly compared NR and NMN in the same participants under the same conditions — so claims that either is definitively superior in humans are not fully supported. Tru Niagen's regulatory standing (GRAS status, NDI history) is more established than NMN's, which went through a period of FDA regulatory uncertainty before the 2025 reversal of the 2022 exclusion rule.

What Tru Niagen won't do

The marketing around Tru Niagen implies anti-aging benefits, energy improvements, and cellular repair — all framed with careful structure/function language, but implying outcomes that haven't been proven in robust long-term human trials. Being the most evidence-backed NR supplement is a real distinction; it is not the same as being proven to extend lifespan or prevent disease in humans. Tru Niagen at 300 mg/day will reliably raise your blood NAD+ by approximately 40–50%. What that elevated NAD+ does for you personally in measurable health terms is, based on the current evidence, genuinely uncertain. If you expect to feel dramatically different within weeks, most users in controlled trials did not report that experience consistently.

See a doctor if: you're on medications metabolized by the liver (NR is processed hepatically), if you have liver disease, or if you're pregnant or nursing. NR is not studied in pregnancy.

Frequently asked questions

Is Tru Niagen the same as the NR used in human clinical trials?
Yes — ChromaDex's Niagen® is the ingredient used in virtually all published NR human trials. This is a genuine differentiator over generic NR brands whose raw material may be equivalent in theory but is untested in peer-reviewed research.

Is 300 mg enough, or should I take 600 mg?
The 300 mg dose raises NAD+ by approximately 40–50% in published trials. The Martens study used 1,000 mg/day; the Dellinger Basis trial used 250–500 mg/day depending on the dose group. There is no clear evidence that doubling from 300 mg to 600 mg produces proportionally greater functional benefit, though it likely produces somewhat greater NAD+ elevation. If you're considering 600 mg/day, it appears safe based on trial data — but the extra benefit over 300 mg is not definitively proven.

How does Tru Niagen compare to Elysium Basis?
Both use Niagen® NR. Elysium Basis adds pterostilbene (50 mg) — a resveratrol analogue that may provide additional sirtuin activation. The Elysium Basis RCT showed 40–90% NAD+ elevation. Tru Niagen is a simpler, purer single-ingredient formula; Basis adds a supporting polyphenol. Both are legitimate options — the pterostilbene addition in Basis is supported by human data (the Dellinger trial), not just theory.

How long until I notice something from Tru Niagen?
Blood NAD+ elevation is detectable within 1–2 weeks in pharmacokinetic studies. Subjective effects (if any) typically emerge in the 4–8 week range based on user reports. Some users report no subjective effects despite confirmed NAD+ elevation — the supplement raises a biomarker; whether that biomarker change translates to something you'll feel is individual and not guaranteed.

The bottom line

Tru Niagen earns its strong reputation: Niagen® NR has the most published human evidence of any NAD+ precursor ingredient, ChromaDex's manufacturing and IP standards are high, and the product's 300 mg dose reliably raises blood NAD+ by 40–50%. The honest limitation is that NAD+ elevation in blood is a surrogate outcome, not a proven clinical benefit. If you're looking for an NR supplement with the strongest research pedigree, Tru Niagen is a defensible choice. If you're evaluating it against broader NAD+ precursor options, our NR vs. NMN vs. NAD+ comparison and best NAD+ supplement guide give fuller context for the decision.

References

1. Martens CR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat Commun. 2018;9:1286. DOI: 10.1038/s41467-018-03421-7. PMID: 29559086
2. Dellinger RW, et al. Repeat dose NRPT increases NAD+ levels in humans safely and sustainably. npj Aging Mech Dis. 2017;3:17. DOI: 10.1038/s41514-017-0016-9
3. Henriquez-Olguin C, et al. Limits of NAD+ precursor supplementation in human ageing. Nature Aging. 2024. DOI: 10.1038/s41514-023-00134-0
4. Conze D, Brenner C, Kruger CL. Safety and metabolism of long-term administration of NIAGEN (nicotinamide riboside chloride) in a randomized, double-blind, placebo-controlled clinical trial of healthy overweight adults. Sci Rep. 2019;9:9772. DOI: 10.1038/s41598-019-46120-z. PMID: 31278342
5. Trammell SA, et al. Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nat Commun. 2016;7:12948. DOI: 10.1038/ncomms12948. PMID: 27721479

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and is not a substitute for professional medical advice.